Suspension of trading

Income Statement ICAD

Stocks

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 23:00:00 16/07/2025 +03			5-day change	1st Jan Change
3.870 ^USD	+3.75%		-.--%	-

21/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
18/07/25	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI

399f2a264a22aa3d0.0LR42TmhVXxal7gq_tubN2lYIZXubiOAEgI_0te_6OU.l_0svm3uDTE85uFFt5rOWywUbN20L0LzTXdFh4XupL2HgjS2f-ZsCBba8Q

Published financial data: ICAD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	29.7M	33.64M	27.94M	17.32M	19.61M
Total Revenues	29.7M	33.64M	27.94M	17.32M	19.61M
Cost of Goods Sold, Total	7.96M	9.08M	7.84M	2.45M	2.59M
Gross Profit	21.73M	24.56M	20.11M	14.87M	17.02M
Selling General & Admin Expenses, Total	22.43M	25.54M	24.92M	17.06M	15.87M
R&D Expenses	8.11M	9.19M	8.59M	5.16M	6.61M
Depreciation & Amortization - (IS)	578K	557K	521K	335K	623K
Other Operating Expenses, Total	31.12M	35.29M	34.04M	22.56M	23.1M
Operating Income	-9.39M	-10.73M	-13.93M	-7.69M	-6.08M
Interest Expense, Total	-476K	-141K	-10K	-16K	-12K
Interest And Investment Income	97K	15K	213K	729K	811K
Net Interest Expenses	-379K	-126K	203K	713K	799K
Other Non Operating Income (Expenses)	-	-	-45K	-14K	-49K
EBT, Excl. Unusual Items	-9.77M	-10.86M	-13.77M	-6.99M	-5.33M
Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-184K
Legal Settlements	-	-	-	-	-
Other Unusual Items	-7.8M	-386K	-	-	-
EBT, Incl. Unusual Items	-17.57M	-11.24M	-13.77M	-6.99M	-5.52M
Income Tax Expense	38K	1K	-116K	20K	98K
Earnings From Continuing Operations	-17.61M	-11.24M	-13.66M	-7.01M	-5.62M
Earnings Of Discontinued Operations	-	-	-	2.16M	-
Net Income to Company	-17.61M	-11.24M	-13.66M	-4.85M	-5.62M
Net Income - (IS)	-17.61M	-11.24M	-13.66M	-4.85M	-5.62M
Net Income to Common Incl Extra Items	-17.61M	-11.24M	-13.66M	-4.85M	-5.62M
Net Income to Common Excl. Extra Items	-17.61M	-11.24M	-13.66M	-7.01M	-5.62M
Per Share Items
Net EPS - Basic	-0.8	-0.45	-0.54	-0.19	-0.21
Basic EPS - Continuing Operations	-0.8	-0.45	-0.54	-0.27	-0.21
Basic Weighted Average Shares Outstanding	22.14M	24.78M	25.2M	25.61M	26.35M
Net EPS - Diluted	-0.8	-0.45	-0.54	-0.19	-0.21
Diluted EPS - Continuing Operations	-0.8	-0.45	-0.54	-0.27	-0.21
Diluted Weighted Average Shares Outstanding	22.14M	24.78M	25.2M	25.61M	26.35M
Normalized Basic EPS	-0.28	-0.27	-0.34	-0.17	-0.13
Normalized Diluted EPS	-0.28	-0.27	-0.34	-0.17	-0.13
Supplemental Items
EBITDA	-8.81M	-10.18M	-13.41M	-7.28M	-5.46M
EBITA	-9.08M	-10.5M	-13.72M	-7.52M	-6.04M
EBIT	-9.39M	-10.73M	-13.93M	-7.69M	-6.08M
EBITDAR	-7.76M	-9.13M	-12.27M	-6.98M	-5.21M
Total Revenues (As Reported)	29.7M	33.64M	27.94M	17.32M	19.61M
Effective Tax Rate - (Ratio)	-0.22	-0.01	0.84	-0.29	-1.78
Current Domestic Taxes	37K	-	-	-	-
Total Current Taxes	37K	-	-	-	-
Deferred Domestic Taxes	1K	1K	-	1K	1K
Deferred Foreign Taxes	-	-	-116K	19K	97K
Total Deferred Taxes	1K	1K	-116K	20K	98K
Normalized Net Income	-6.1M	-6.79M	-8.61M	-4.37M	-3.33M
Interest on Long-Term Debt	476K	141K	10K	16K	12K
Supplemental Operating Expense Items
Advertising Expense	211K	689K	659K	200K	477K
Selling and Marketing Expenses	13.31M	15.14M	13.69M	7.74M	8.42M
General and Administrative Expenses	9.12M	10.41M	11.23M	9.32M	7.44M
Research And Development Expense From Footnotes	8.11M	9.19M	8.59M	5.16M	6.61M
Net Rental Expense, Total	1.05M	1.05M	1.14M	298K	254K
Imputed Operating Lease Interest Expense	256K	238K	40.03K	67.33K	59.26K
Imputed Operating Lease Depreciation	793K	810K	1.1M	231K	195K
Stock-Based Comp., COGS (Total)	30K	15K	3K	2K	1K
Stock-Based Comp., R&D Exp. (Total)	376K	356K	220K	222K	134K
Stock-Based Comp., S&M Exp. (Total)	657K	785K	518K	308K	158K
Stock-Based Comp., G&A Exp. (Total)	1.78M	1.63M	945K	784K	590K
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	2.84M	2.78M	1.69M	1.32M	883K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	27.19M	34.28M	21.31M	21.67M	17.21M
Total Cash And Short Term Investments	27.19M	34.28M	21.31M	21.67M	17.21M
Accounts Receivable, Total	10.51M	10.79M	9.66M	6.39M	7.22M
Total Receivables	10.51M	10.79M	9.66M	6.39M	7.22M
Inventory	3.14M	4.17M	5.39M	917K	756K
Prepaid Expenses	1.06M	765K	1.64M	699K	1.25M
Other Current Assets, Total	406K	302K	241K	-	-
Total Current Assets	42.3M	50.31M	38.24M	29.68M	26.43M
Gross Property Plant And Equipment	9.28M	9.05M	6.57M	3.33M	3.39M
Accumulated Depreciation	-6.78M	-7.11M	-2.14M	-1.04M	-1.5M
Net Property Plant And Equipment	2.5M	1.94M	4.44M	2.28M	1.89M
Goodwill	8.36M	8.36M	8.36M	8.36M	8.36M
Other Intangibles, Total	889K	683K	482K	148K	101K
Accounts Receivable Long-Term	1.43M	844K	15K	157K	-
Deferred Tax Assets Long-Term	-	-	116K	97K	-
Other Long-Term Assets, Total	93K	55K	54K	692K	757K
Total Assets	55.58M	62.19M	51.7M	41.42M	37.54M
Liabilities
Accounts Payable, Total	2.87M	2.78M	1.97M	712K	1.11M
Accrued Expenses, Total	7.04M	5.64M	4.68M	2.45M	2.36M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	726K	889K	582K	188K	229K
Unearned Revenue Current, Total	6.12M	5.65M	6.22M	3.4M	3.86M
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	16.75M	14.96M	13.45M	6.75M	7.56M
Long-Term Debt	6.96M	-	-	-	-
Long-Term Leases	1.08M	266K	2.8M	273K	133K
Unearned Revenue Non Current	267K	441K	542K	974K	1.14M
Deferred Tax Liability Non Current	4K	5K	6K	6K	8K
Other Non Current Liabilities	-	-	-	-	17K
Total Liabilities	25.06M	15.67M	16.8M	8M	8.86M
Common Stock, Total	236K	253K	254K	265K	265K
Additional Paid In Capital	274M	301M	303M	306M	307M
Retained Earnings	-242M	-253M	-267M	-272M	-277M
Treasury Stock	-1.42M	-1.42M	-1.42M	-1.42M	-1.42M
Total Common Equity	30.52M	46.52M	34.9M	33.42M	28.68M
Total Equity	30.52M	46.52M	34.9M	33.42M	28.68M
Total Liabilities And Equity	55.58M	62.19M	51.7M	41.42M	37.54M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	24.92M	25.17M	25.26M	26.35M	27.18M
ECS Total Common Shares Outstanding	23.51M	25.14M	25.26M	26.35M	26.35M
Book Value / Share	1.3	1.85	1.38	1.27	1.09
Tangible Book Value	21.27M	37.47M	26.06M	24.91M	20.22M
Tangible Book Value Per Share	0.9	1.49	1.03	0.95	0.77
Total Debt	8.76M	1.16M	3.38M	461K	362K
Net Debt	-18.42M	-33.13M	-17.93M	-21.21M	-16.84M
Debt Equivalent Oper. Leases	8.39M	8.38M	9.09M	2.38M	2.03M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.36M	2.96M	2.66M	583K	545K
Inventories - Work In Process, Total	76K	173K	101K	55K	42K
Inventories - Finished Goods, Total	1.71M	1.28M	2.89M	324K	224K
Machinery, Total	7.08M	7.44M	3.1M	1.59M	1.58M
Full Time Employees	113	136	108	67	66
Part Time Employees	1	1	1	2	-
Accumulated Allowance for Doubtful Accounts (Supple)	111K	268K	922K	277K	238K

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-17.61M	-11.24M	-13.66M	-4.85M	-5.62M
Depreciation & Amortization - CF	268K	327K	310K	239K	577K
Amortization of Goodwill and Intangible Assets - (CF)	309K	230K	211K	170K	47K
Depreciation & Amortization, Total	577K	557K	521K	409K	624K
Amortization of Deferred Charges, Total - (CF)	78K	17K	-	-	-
(Gain) Loss From Sale Of Asset	-	97K	-	-2.59M	-
Asset Writedown & Restructuring Costs	-	-	-	-	184K
Stock-Based Compensation (CF)	2.84M	2.78M	1.69M	1.32M	883K
Provision and Write-off of Bad Debts	94K	167K	732K	177K	-39K
Other Operating Activities, Total	7.81M	387K	601K	481K	264K
Change In Accounts Receivable	-302K	969K	-739K	419K	-776K
Change In Inventories	-533K	-1.03M	-1.22M	1.49M	161K
Change In Accounts Payable	878K	-90K	-806K	-811K	399K
Change in Unearned Revenues	780K	-291K	665K	193K	626K
Change in Other Net Operating Assets	-1.6M	-1.73M	-576K	-1.2M	-655K
Cash from Operations	-6.98M	-9.41M	-12.79M	-4.96M	-3.94M
Capital Expenditure	-461K	-563K	-524K	-922K	-168K
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	4.54M	-
Sale (Purchase) of Intangible assets	-13K	-24K	-10K	-342K	-351K
Cash from Investing	-474K	-587K	-534K	3.28M	-519K
Long-Term Debt Issued, Total	7.73M	-	-	-	-
Total Debt Issued	7.73M	-	-	-	-
Long-Term Debt Repaid, Total	-7.41M	-7.36M	-	-	-
Total Debt Repaid	-7.41M	-7.36M	-	-	-
Issuance of Common Stock	19.28M	24.51M	355K	2.05M	-
Repurchase of Common Stock	-225K	-59K	-	-	-
Other Financing Activities, Total	-42K	-	-	-	-
Cash from Financing	19.33M	17.09M	355K	2.05M	-
Net Change in Cash	11.87M	7.1M	-12.97M	357K	-4.46M
Supplemental Items
Cash Interest Paid	272K	172K	9K	16K	12K
Cash Income Tax Paid (Refund)	38K	-	-	-	-
Levered Free Cash Flow	-2.18M	-6.89M	-9.15M	-2.11M	-3.26M
Unlevered Free Cash Flow	-1.96M	-6.81M	-9.14M	-2.1M	-3.26M
Change In Net Working Capital	-964K	2.86M	2.11M	-2.24M	441K
Net Debt Issued / Repaid	319K	-7.36M	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-12.06	-11.39	-15.29	-10.32	-9.63
Return on Total Capital	-17.56	-15.43	-20.26	-13.84	-12.09
Return On Equity %	-98.94	-29.19	-33.54	-20.52	-18.09
Return on Common Equity	-98.94	-29.19	-33.54	-20.52	-18.09
Margin Analysis
Gross Profit Margin %	73.18	73.01	71.96	85.87	86.78
SG&A Margin	75.52	75.93	89.2	98.53	80.93
EBITDA Margin %	-29.67	-30.25	-47.99	-42.04	-27.85
EBITA Margin %	-30.57	-31.22	-49.09	-43.42	-30.79
EBIT Margin %	-31.61	-31.9	-49.85	-44.4	-31.03
Income From Continuing Operations Margin %	-59.3	-33.43	-48.87	-40.48	-28.64
Net Income Margin %	-59.3	-33.43	-48.87	-27.99	-28.64
Net Avail. For Common Margin %	-59.3	-33.43	-48.87	-40.48	-28.64
Normalized Net Income Margin	-20.55	-20.17	-30.8	-25.23	-17
Levered Free Cash Flow Margin	-7.33	-20.47	-32.73	-12.18	-16.64
Unlevered Free Cash Flow Margin	-6.59	-20.26	-32.71	-12.12	-16.6
Asset Turnover
Asset Turnover	0.61	0.57	0.49	0.37	0.5
Fixed Assets Turnover	10.88	15.14	8.77	9.47	9.39
Receivables Turnover (Average Receivables)	2.92	3.16	2.73	2.68	2.88
Inventory Turnover (Average Inventory)	2.77	2.48	1.64	1.65	3.1
Short Term Liquidity
Current Ratio	2.53	3.36	2.84	4.4	3.5
Quick Ratio	2.25	3.01	2.3	4.16	3.23
Operating Cash Flow to Current Liabilities	-0.42	-0.63	-0.95	-0.74	-0.52
Days Sales Outstanding (Average Receivables)	125.34	115.53	133.51	136.04	127.02
Days Outstanding Inventory (Average Inventory)	132.22	147.06	222.68	221.58	118.12
Average Days Payable Outstanding	104.64	102	95.8	300.64	137.23
Cash Conversion Cycle (Average Days)	152.93	160.58	260.4	56.98	107.91
Long Term Solvency
Total Debt/Equity	28.7	2.48	9.7	1.38	1.26
Total Debt / Total Capital	22.3	2.42	8.84	1.36	1.25
LT Debt/Equity	26.32	0.57	8.03	0.82	0.46
Long-Term Debt / Total Capital	20.45	0.56	7.32	0.81	0.46
Total Liabilities / Total Assets	45.08	25.2	32.5	19.32	23.59
EBIT / Interest Expense	-19.72	-76.11	-1.39K	-480.56	-507
EBITDA / Interest Expense	-16.31	-64.73	-1.23K	-436.38	-433.83
(EBITDA - Capex) / Interest Expense	-17.28	-68.72	-1.28K	-494	-447.83
Total Debt / EBITDA	-1.13	-0.13	-0.28	-0.07	-0.07
Net Debt / EBITDA	2.37	3.63	1.46	3.04	3.24
Total Debt / (EBITDA - Capex)	-1.07	-0.12	-0.26	-0.06	-0.07
Net Debt / (EBITDA - Capex)	2.24	3.42	1.4	2.68	3.13
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-5.24	13.27	-16.93	-12.54	13.22
Gross Profit, 1 Yr. Growth %	-11.74	13.01	-18.12	-12.15	14.42
EBITDA, 1 Yr. Growth %	53.96	15.48	31.78	-24.77	-25
EBITA, 1 Yr. Growth %	50.81	15.67	30.63	-24.71	-19.71
EBIT, 1 Yr. Growth %	46.76	14.32	29.8	-24.6	-20.87
Earnings From Cont. Operations, 1 Yr. Growth %	29.95	-36.14	21.44	-29.32	-19.89
Net Income, 1 Yr. Growth %	29.95	-36.14	21.44	-64.51	15.87
Normalized Net Income, 1 Yr. Growth %	42.86	11.17	26.84	-30.34	-23.69
Diluted EPS Before Extra, 1 Yr. Growth %	8.11	-43.27	19.4	-30.45	-22.14
Accounts Receivable, 1 Yr. Growth %	6.86	2.65	-10.47	-1.92	12.92
Inventory, 1 Yr. Growth %	20.41	32.67	29.2	-55.36	-17.56
Net Property, Plant and Equip., 1 Yr. Growth %	-15.39	-22.42	128.49	66.23	-17.12
Total Assets, 1 Yr. Growth %	33.14	11.89	-16.86	-19.9	-9.36
Tangible Book Value, 1 Yr. Growth %	-575.5	76.14	-30.46	-5.21	-18.81
Common Equity, 1 Yr. Growth %	501.95	52.39	-24.97	-4.25	-14.16
Cash From Operations, 1 Yr. Growth %	-1.72	34.69	35.95	-61.19	-20.53
Capital Expenditures, 1 Yr. Growth %	55.74	22.13	-6.93	75.95	-81.78
Levered Free Cash Flow, 1 Yr. Growth %	-58.16	216.43	32.83	-67.29	54.67
Unlevered Free Cash Flow, 1 Yr. Growth %	-59.74	248.3	34.13	-67.41	55.05
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	7.66	3.6	-3	-28.25	-0.49
Gross Profit, 2 Yr. CAGR %	4.68	-0.13	-3.81	-22.19	0.26
EBITDA, 2 Yr. CAGR %	20.96	33.34	23.36	-15.41	-24.89
EBITA, 2 Yr. CAGR %	19.6	32.08	22.93	-15.39	-22.25
EBIT, 2 Yr. CAGR %	18.11	29.52	21.81	-15.36	-22.76
Earnings From Cont. Operations, 2 Yr. CAGR %	39.75	-8.91	-11.94	-21.05	-24.75
Net Income, 2 Yr. CAGR %	39.75	-8.91	-11.94	-34.35	-35.87
Normalized Net Income, 2 Yr. CAGR %	17.09	26.02	18.75	-19.77	-27.09
Diluted EPS Before Extra, 2 Yr. CAGR %	21.67	-21.69	-17.7	-22.34	-26.41
Accounts Receivable, 2 Yr. CAGR %	27.92	4.73	-4.13	-23.02	5.24
Inventory, 2 Yr. CAGR %	40.75	26.39	30.92	-53.11	-39.33
Net Property, Plant and Equip., 2 Yr. CAGR %	112.9	-18.98	33.14	8.48	17.38
Total Assets, 2 Yr. CAGR %	32.34	22.05	-3.55	-18.39	-14.79
Tangible Book Value, 2 Yr. CAGR %	165.59	189.4	10.67	-18.47	-12.28
Common Equity, 2 Yr. CAGR %	110.39	202.87	6.93	-15.24	-9.34
Cash From Operations, 2 Yr. CAGR %	34.4	15.06	35.32	-27.36	-44.46
Capital Expenditures, 2 Yr. CAGR %	23.76	37.91	6.61	27.97	-43.38
Levered Free Cash Flow, 2 Yr. CAGR %	115	15.06	105.02	-44.65	-28.87
Unlevered Free Cash Flow, 2 Yr. CAGR %	78.25	18.41	116.14	-44.49	-28.92
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.86	9.5	-3.75	-16.45	-16.47
Gross Profit, 3 Yr. CAGR %	2.45	7.39	-6.53	-11.88	-11.51
EBITDA, 3 Yr. CAGR %	5.54	19.11	32.82	-6.16	-18.74
EBITA, 3 Yr. CAGR %	2.26	18.28	31.6	-6.09	-16.85
EBIT, 3 Yr. CAGR %	1.48	16.83	29.62	-6.44	-17.24
Earnings From Cont. Operations, 3 Yr. CAGR %	7.3	7.64	0.26	-26.44	-20.66
Net Income, 3 Yr. CAGR %	7.3	7.64	0.26	-34.95	-20.66
Normalized Net Income, 3 Yr. CAGR %	2.43	15.08	26.29	-10.55	-21.1
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.84	-5.66	-9.87	-30.06	-22.27
Accounts Receivable, 3 Yr. CAGR %	6.91	18.87	-0.6	-15.27	-12.53
Inventory, 3 Yr. CAGR %	13.98	38	27.32	-33.68	-43.41
Net Property, Plant and Equip., 3 Yr. CAGR %	63.16	52.06	14.47	-2.99	-0.83
Total Assets, 3 Yr. CAGR %	20.04	25.14	7.39	-9.34	-15.49
Tangible Book Value, 3 Yr. CAGR %	74.8	131.61	79.92	5.4	-18.59
Common Equity, 3 Yr. CAGR %	28.83	88.95	90.22	3.06	-14.88
Cash From Operations, 3 Yr. CAGR %	-1.63	34.5	21.64	-10.76	-25.15
Capital Expenditures, 3 Yr. CAGR %	5.73	23.21	20.97	25.99	-33.18
Levered Free Cash Flow, 3 Yr. CAGR %	-9.58	144.56	20.7	-1.03	-22.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	-11.95	122.85	23.43	2.38	-21.83
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-6.5	5.01	-0.11	-7.53	-8.95
Gross Profit, 5 Yr. CAGR %	-6.9	4.5	-0.1	-5.6	-7.12
EBITDA, 5 Yr. CAGR %	65.39	5.83	12.34	3.87	-0.94
EBITA, 5 Yr. CAGR %	59.92	3.16	10.08	3.45	0.06
EBIT, 5 Yr. CAGR %	28.92	1.48	9.17	2.7	-1
Earnings From Cont. Operations, 5 Yr. CAGR %	-11.51	2.17	-0.86	-4.91	-16.15
Net Income, 5 Yr. CAGR %	-11.51	2.17	-0.86	-11.68	-16.15
Normalized Net Income, 5 Yr. CAGR %	24.5	1.61	8.67	-0.38	-4.84
Diluted EPS Before Extra, 5 Yr. CAGR %	-17.32	-6.46	-9.08	-12.72	-22.04
Accounts Receivable, 5 Yr. CAGR %	7.01	15.76	2.35	-0.09	-6
Inventory, 5 Yr. CAGR %	-6.14	2.28	20.48	-10.39	-21.96
Net Property, Plant and Equip., 5 Yr. CAGR %	1.64	6.98	50.42	32.85	-8.53
Total Assets, 5 Yr. CAGR %	2.7	9.98	9.98	5.47	-2.1
Tangible Book Value, 5 Yr. CAGR %	8.31	37.02	45.59	52.54	35.21
Common Equity, 5 Yr. CAGR %	-1.39	13.19	19.58	37.11	41.42
Cash From Operations, 5 Yr. CAGR %	29.74	11.42	11.76	5.12	-11.11
Capital Expenditures, 5 Yr. CAGR %	-13.13	10.81	6.08	25.09	-10.71
Levered Free Cash Flow, 5 Yr. CAGR %	10.37	36.89	25.45	34.98	-8.9
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.23	37.82	26.1	27.8	-7.7